Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow
β Scribed by Taylor, P R A; Jackson, G H; Lennard, A L; Hamilton, P J; Proctor, S J
- Book ID
- 110053636
- Publisher
- Nature Publishing Group
- Year
- 1997
- Tongue
- English
- Weight
- 185 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Allogeneic blood and marrow transplantation (alloBMT) remains the only curative treatment for patients with myelodysplastic syndromes (MDS), but its application has been limited by the older age range of patients with this disease. T cell depletion decreases transplant-related toxicity related to gr
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome (t-AML/ MDS) are being reported with increasing frequency as a complication of ABMT for Hodgkin's disease and non-Hodgkin's lymphoma. At present there is no method available to predict who is at risk or is destined to develop th
Pulmonary interstitial infiltrates are a common diagnostic dilemma following bone-marrow transplantation. We present a case report of a child presenting with recurrent, metastatic neuroblastoma after bone-marrow transplantation, manifested initially as pulmonary interstitial disease mimicking idiopa